Target intelligence / Profile preview

Non-specific blood and vascular components

Molecular classification
Other
01

Overview

Non-specific blood and vascular components is a pharmacological classification used to describe therapeutic interventions that act through physical or broad physiological mechanisms within the circulatory system rather than by binding to a specific molecular target like a receptor or enzyme (ChEMBL, CHEMBL614451). This category typically includes plasma expanders, such as albumin and dextrans, and osmotic agents like mannitol, which are used to manage intravascular volume and fluid distribution (StatPearls, NBK551644). These agents are primarily utilized in clinical settings to treat conditions such as hypovolemic shock, hemorrhage, and cerebral edema by modulating oncotic or osmotic pressure (PubMed, PMID: 28613507). Because these effects are mediated by the collective properties of blood or the physical space of the vasculature, this "target" does not correspond to a single gene product or protein structure. Consequently, it is often used as a placeholder in drug databases for agents with non-specific or physical modes of action (PubMed, PMID: 30020619).

Other names
Blood componentsVascular componentsPlasmaIntravascular volumeWhole blood
02

Mechanism of action

Expansion of intravascular volume through increased oncotic pressure or osmotic fluid shifts.

03

Biological functions

Osmotic balanceBlood pressure regulationHemostasisOxygen transportMaintenance of intravascular volume
04

Disease associations

HypovolemiaShockHemorrhageEdemaCerebral edema
05

Safety considerations

Fluid overloadPulmonary edemaAnaphylactoid reactionsCoagulopathyAcute kidney injuryElectrolyte imbalance
06

Interacting drugs

Albumin

6 more in the full profile.

07

Biomarkers

HematocritMean arterial pressurePlasma osmolarityCentral venous pressureUrine output

Beyond the preview

Go deeper on Non-specific blood and vascular components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific blood and vascular components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call